About
Company Overview
Management
Board of Directors
Advisory Board
Collaborations
Partner Collaborations
Scientific & Research Collaborations
Patients
Patients Overview
About Clinical Studies
Current Studies
Sponsored
TakeAim Lymphoma
TakeAim Leukemia
Studies Now Enrolling
Pipeline
Pipeline Overview
CA-4948
Fimepinostat
CA-170
CA-327
Erivedge
®
Scientific Resources
Investors
Overview
Press Releases
Events & Presentations
Corporate Governance
Committee Composition
Contact the Board
Financial Information
SEC Filings
Annual Reports
IRS Form 8937
Stock Performance
Historical Stock Lookup
Analyst Coverage
Contact Us
Careers
Life at Curis
Open Positions
Benefits
Contact
About
Company Overview
Management
Board of Directors
Advisory Board
Collaborations
Partner Collaborations
Scientific & Research Collaborations
Patients
Patients Overview
About Clinical Studies
Current Studies
Sponsored
TakeAim Lymphoma
TakeAim Leukemia
Studies Now Enrolling
Pipeline
Pipeline Overview
CA-4948
Fimepinostat
CA-170
CA-327
Erivedge
®
Scientific Resources
Overview
Press Releases
Events & Presentations
Corporate Governance
Financial Information
SEC Filings
Annual Reports
IRS Form 8937
Stock Performance
Contact Us
Careers
Life at Curis
Open Positions
Benefits
Contact
IRS Form 8937
2023 Reverse Stock Split
Download IRS Form 8937
November 8, 2023
(1.5 MB)
About
Company Overview
Management
Board of Directors
Advisory Board
Collaborations
Partner Collaborations
Scientific & Research Collaborations
Patients
Patients Overview
About Clinical Studies
Current Studies
Sponsored
TakeAim Lymphoma
TakeAim Leukemia
Studies Now Enrolling
Pipeline
Pipeline Overview
CA-4948
Fimepinostat
CA-170
CA-327
Erivedge
®
Scientific Resources
Investors
Overview
Press Releases
Events & Presentations
Corporate Governance
Financial Information
SEC Filings
Annual Reports
IRS Form 8937
Stock Performance
Contact Us
Careers
Life at Curis
Open Positions
Benefits
Contact